Maintain JPM neutral weight with pre-committed tiered add framework and hard stop at $335
Maintain core position. Do not add at current price of $356. Pre-commit to tiered add framework with each tranche sized at half the original position size. Hard stop $335 (below 50 SMA). Q3 2026 earnings mid-October resolves Q2 comp-distortion, NII trajectory under 86% no-cut pricing, and credit-card delinquency disclosure — clean beat-and-raise above $6.40 adjusted EPS upgrades to Overweight; miss below $5.50 triggers Underweight reassessment.
| Position | Action |
|---|---|
| Tranche 1 entry at $340-345 zone | 25% of original position size with bullish reversal candle and volume confirmation |
| Tranche 2 entry at $330-335 zone | 25% of original position size if macro backdrop deteriorates (2s10s un-inversion, dovish Fed surprise below 50% no-cut, or recession confirmation) |
| Tranche 3 entry on breakout above $366.50 | 25% of original position size on confirmed close above $366.50 on volume >6M with positive MACD histogram cross and RSI >65 |
| Tranche 4 reserved capital | 25% reserved for confirmed breakout conditions |
| Retest of $365-367 without fresh catalysts | Trim 10-15% partial position |
| Close at $312.81 (200 SMA) | Full exit |
JPMorgan Chase is the best-positioned bank in America at the most constructive moment of the cycle, with record earnings power, premium-but-justified valuation, constructive technical setup, NIM-supportive macro, and multiple unpriced strategic growth vectors; the path of least resistance is up.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $356.87 | neutral |
| 50 SMA | $345.90 | bullish |
| 200 SMA | $314.57 | bullish |
| RSI (14-day) | 54.27 | neutral |
| MACD | 3.10 | bearish |
| MACD Signal | 4.68 | bearish |
| MACD Histogram | −1.58 | bearish |
| ATR | 5.96 | neutral |
| Bollinger Upper Band (2σ) | $366.45 | neutral |
| Bollinger Middle (20 SMA) | $357.65 | neutral |
| Bollinger Lower Band (2σ) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Valuation premium justified by industry-leading ROE spread — 580 basis points above cost of equity
EV: +8.1% ($356 → $385 over 3-6 months)
JPMorgan's stock is priced for perfection at all-time-high multiples on inflated earnings, unsustainable ROE, and peak institutional positioning—creating a high-conviction short as credit cycles turn, leverage builds dangerously, and the Dimon succession risk looms unquantified.
EV: -$310 to -$320 base case over 3-6 months; -$280 to -$290 bear case if credit cycle turns in Q4 2026/Q1 2027 (representing 30-37% downside from $356.50) · concedes: Dimon is a highly capable leader and JPM is the best-positioned bank; Near-term NIM tailwind from no Fed cuts is real; Credit deterioration has not materialized yet; The stock could trade higher in the short term before fundamentals matter; Buy-in zone at $310-$320 would represent a more reasonable entry for long-term investors
→ vs conservative: Waiting for $330 entry is anchoring to levels that may never come; $24.8B allowance for credit losses is more than adequately provisioned against 8% recession probability
→ vs conservative: Leverage expansion to $223B net debt reflects strategic balance sheet deployment at peak earning power, not structural weakness; $310B TCE base and 12%+ stress capital buffer remain robust
→ vs conservative: Credit cycle has been 'imminent' for 18 months while net charge-offs remained subdued for six consecutive quarters
→ vs neutral: Breakout checklist (volume 1.5x average, RSI above 60) is academic; by the time all criteria confirm, price will be at $372 with limited upside left
→ vs neutral: Bear case is cyclical, well-priced, and contingent on credit deterioration not materialized for six quarters; bull case is structural and multi-year
| $348.85 |
| neutral |
Support: 354.6 · 351.55 · 348.85 · 345.9 | Resistance: 357.65 · 362 · 363 · 366.09 · 366.45
JPM is in a structurally bullish posture that is digesting recent gains after rallying to $365.18 on 8/12. The stock trades decisively above rising 50 SMA ($345.90, +3.1%) and 200 SMA ($314.57, +13.3%), confirming a long-term uptrend. Short-term momentum has reset—RSI pulled back from 68.92 to 54.27 and MACD has turned bearish below its signal line—while volatility has compressed (ATR contracted from $7.30 to $5.96). The 10 EMA ($356.87) is flat, with price hugging the middle Bollinger Band, indicating equilibrium. Bears attempted a breakdown on 8/20 (low of $351.55) but were rejected, and the setup suggests a coiled spring primed for a continuation move. Action bias: Bullish; hold existing longs or buy a breakout above $366.45 or a pullback to the $345-$348 zone.
Market Cap
$947.6B
P/E (TTM)
15.28x
Forward P/E
14.26x
PEG Ratio
1.72
P/B
2.68x
EPS (TTM)
$23.33
Forward EPS
$25.01
Dividend Yield
1.68%
Beta
0.977
52-Week High
$366.50
52-Week Low
$279.10
50-Day Avg
$345.52
200-Day Avg
$316.53
Operating Margin
50.4%
Net Profit Margin
34.9%
ROE (TTM)
17.8%
ROA (TTM)
1.36%
Book Value/Share
$133.01
2025 Total Revenue
$181.847B
2025 Net Interest Income
$95.443B
2025 Pretax Income
$72.595B
2025 Net Income
$57.048B
2025 Diluted EPS
$20.02
2025 Diluted Shares
~2,781M
TTM (Q2'26 LTM) Total Revenue
$186.328B
TTM (Q2'26 LTM) Net Income
$63.634B
2026-Q2 Revenue
$52.85B
2026-Q2 Net Income
$21.16B
2026-Q2 Diluted EPS
$7.70
Revenue CAGR (2022-25)
~12.4%
EPS CAGR (2022-25)
~18%
Q2'26 Total Assets
$5,015B
Q2'26 Net Loans
$1,516B
Q2'26 Total Debt
$533B
Q2'26 Stockholders' Equity
$375B
Q2'26 Tangible Book Value
$310B
2025 Annual Buyback
$31.6B
2025 Annual Dividends
$16.6B
Total Shareholder Yield
~5.3%
Net Debt (Q2'26)
$223B
Cash & Equivalents
$310B
Cash + Fed Funds Sold
$756B
Trading Securities (Q2'26)
$794B
2026 H1 Asset Growth (annualized)
>20%
Share Count Reduction (since 2022)
~9.6%
Strengths
Concerns
JPMorgan Chase demonstrates exceptional fundamentals with record Q2 2026 earnings of $7.70 EPS on $52.85B revenue, supported by a 17.8% ROE and nearly 5.3% total shareholder yield through aggressive buybacks and dividends. The bank faces balance sheet leverage concerns with assets growing >20% annualized while equity grew only ~3%, and net debt tripled to $223B, though the 2.68x P/B multiple remains justified by industry-leading profitability and strong capital return capacity. The primary investment thesis centers on capital markets cycle tailwinds, wealth management expansion, and the potential removal of Dimon succession overhang, balanced against credit cycle and regulatory risks.
Macro: Fed policy: 87% probability of zero cuts in 2026 (1-week +2.1pp), 40% odds of ≥1 hike, 16% odds of ≥2 hikes. Soft landing at YE 2026: 62% vs 33% overheating. US recession by YE 2026: 8%. US sovereign default by 2027: 3%. 10Y Treasury hitting 4.8% by 2027: 65% (-1.5pp 1-wk). 10Y Treasury hitting 5.0% by 2027: 16% (-21pp 1-wk). PCE re-acceleration: gold sold off on the print, hawkish read supporting NIM but pressuring CRE/MBS.